Esaote Group: Shareholders' Meeting approves financial statements as of 31 December 2023
Published on 08/07/2025 at 18:05 | prnewswire.co.uk
Consolidated revenues up to €273.2 million (+6.5%), EBITDA stands at €41.7 million (+24.5%); EBIT up to €13.4 million and net profit up to €6.2 million.Sales increased in all business lines, especially in the ultrasound segment (+9.7%). Second consecutive record sales year for MRI (+3.3%).Continued expansion phase: average annual growth of 7.6% over the last 4 years.Esaote firmly among the world's leading medical imaging manufacturers with a strategy focused on innovation, quality, people and product portfolio differentiation.Strengthened presence in international markets representing 64.5% of total revenues. Invested €32.9 million in R&D. Continued commitment to Sustainability.View original content:https://www.prnewswire.co.uk/news-releases/esaote-group-shareholders-meeting-approves-financial-statements-as-of-31-december-2023-302123845.html
en | boerse | 67974736 |
